Research Alliance Corp III (RACC) Corporate Subsidiaries
Research Alliance Corp III (RACC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RACC
CIK: 2118032
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 2/25/2026 12:00:00 AM
Lead Engagement PartnerAlan Markowitz
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-07 | — | SCHEDULE 13G Filing | 0001104659-26-114377 | View SEC Doc Filr Page |
| S-4/A | 2026-09-28 | — | S-4/A | 0001193125-26-403078 | View SEC Doc Filr Page |
| 425 | 2026-09-16 | — | 425 | 0001193125-26-392963 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-11 | — | SCHEDULE 13G Filing | 0001172661-26-004339 | View SEC Doc Filr Page |
| 425 | 2026-09-11 | — | 425 | 0001193125-26-388359 | View SEC Doc Filr Page |
| S-4 | 2026-08-24 | — | S-4 | 0001193125-26-363800 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097423 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352319 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003434 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0000902664-26-003433 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346912 | View SEC Doc Filr Page |
| 425 | 2026-08-05 | — | 425 | 0001193125-26-335338 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0000070858-26-000405 | View SEC Doc Filr Page |
| 425 | 2026-07-29 | — | 425 | 0001193125-26-321743 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-28 | — | SCHEDULE 13D/A Filing | 0002135648-26-000011 | View SEC Doc Filr Page |
| 425 | 2026-07-28 | — | 425 | 0001193125-26-318558 | View SEC Doc Filr Page |
| 425 | 2026-07-27 | — | 425 | 0001193125-26-316960 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-26 | 8-K | 0001193125-26-316954 | View SEC Doc Filr Page |
| 10-Q | 2026-07-02 | 2026-03-31 | 10-Q | 0001193125-26-294451 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-29 | — | SCHEDULE 13G Filing | 0000921895-26-001505 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-05-29 | — | SCHEDULE 13D Filing | 0002135648-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-29 | — | SCHEDULE 13G Filing | 0001493152-26-026372 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-21 | 8-K | 0001193125-26-245567 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-28 | — | SCHEDULE 13G Filing | 0001831942-26-000026 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-28 | — | SCHEDULE 13G Filing | 0001193125-26-245154 | View SEC Doc Filr Page |